| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 03/02/2005 | CN1191266C Compositions for treating inflammatory response |
| 03/02/2005 | CN1191249C Quinoline and quinazoline compound for treating benign prostatic hyperplasia specially |
| 03/02/2005 | CN1191236C Substituted 6,6-Hetero-dicycloderivative |
| 03/02/2005 | CN1191084C Medicated wine and its production process |
| 03/02/2005 | CN1191079C Chinese medicine preparation for curing urinaemia |
| 03/02/2005 | CN1191071C Product of ginsenoside mono compatibility for improving sextual function |
| 03/01/2005 | US6861444 Treating or preventing diabetes, obesity, hyperlipidemia, digestive diseases, depression or urinary disturbances; adrenergic blocking agents |
| 03/01/2005 | US6861418 Modulating protein kinase signal transduction; anticancer agents |
| 03/01/2005 | US6861417 Such as 2-(4-fluorophenyl)-3-(pyridin-4-yl)pyrazine for treating cytokine mediated diseases such as psoriatic arthritis |
| 03/01/2005 | US6861409 Compounds for use in the dtreatment of growth metabolic disorders |
| 03/01/2005 | US6861404 Therapies for chronic renal failure |
| 03/01/2005 | US6861072 Pharmaceutical composition with gastric residence and controlled release |
| 02/24/2005 | WO2005016928A1 Imidazopyridine derivatives |
| 02/24/2005 | WO2005016911A1 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors |
| 02/24/2005 | WO2004066990B1 Methods of treating lower urinary tract disorders using sodium channel modulators |
| 02/24/2005 | WO2003018758A3 Reagents and methods for smooth muscle therapies |
| 02/24/2005 | US20050043544 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
| 02/24/2005 | US20050043536 Sulfonamides |
| 02/24/2005 | US20050043408 Prevent protein glycation; drug screening; using epinephrine compound |
| 02/24/2005 | US20050043386 2-amino-2-(ethyl or methyl)-4-{5-substituted pyrrol-2-yl}butan-1-ols, phosphates and phosphonates; antiarthritic agents; psoriasis; immunosuppressants |
| 02/24/2005 | US20050043362 Use of compounds |
| 02/24/2005 | US20050043352 human YAK family of serine/threonine protein kinases (hyak); use treating diseases of the hematopoietic systems, including anemias, polycythemia, myelodysplastic syndrome, myelosuppression, cytopenia, male contraceptives; 2-(3-Chloro-phenylamino)-7-methoxy-quinoline-3-carboxylic acid for example |
| 02/24/2005 | US20050043350 Administering heterocyclic ether such as 5-chloro-7-hydroxy-3-(4-hydroxyphenylz)-4-oxo-1-benzopyran for prophylaxis of Alzheimer's disease, osteoporosis, cardiovascular disorders, psychological disorders, antiarthritic agents,anxiolytic agents |
| 02/24/2005 | US20050043349 1-Alkyl-1-azoniabicyclo' 2.2.!octane carbamate derivatives and their use as muscarinic receptor antagonists |
| 02/24/2005 | US20050043346 Pyridylpyrrole derivatives active as kinase inhibitors |
| 02/24/2005 | US20050043337 Selective beta3 adrenergic agonists |
| 02/24/2005 | US20050043336 Quinazoline derivatives as antitumor agents |
| 02/24/2005 | US20050043332 Such as 4 (cis-3-hydroxycyclopentyl)amino-5,6-dimethyl-2-phenyl-7H-pyrrolo[2,3d] pyrimidine for treatment of adenosine receptor stimulated diseases, cardiovascular disorders, and nervous system disorders |
| 02/24/2005 | US20050043328 Such as 6-(2-hydroxy-3-chloroxybenzylamino)purine, 6-(2-hydroxy-4-chlorobenzylamino)purine; agriculture; cloning; immunostimulation |
| 02/24/2005 | US20050043303 prophylaxis of cardiovascular disorders comprising administering to mammals inhibitors of cyclic guanosine monophosphate metabolizing phosphodiesterases such as 2-{2-Ethoxy-5-[4-(2-hydroxy-ethyl)-piperazine-1-sulfonyl]-phenyl}-6-methyl-8-propyl-3H-imidazo[1,5-a][1,3,5]triazin-4-one; antiarrythmic agents |
| 02/24/2005 | US20050043281 administering for treatment of metabolic bone diseases, mobilizing calcium for osteoporosis, imbalances in the immune system |
| 02/24/2005 | US20050042738 Carbohydrate-associated proteins |
| 02/24/2005 | US20050042731 Four helical bundle cytokine family polypeptide for use in treatment, diagnosis and prevention of infection, cardiovascular, metabolic, developmental, skin, bone, inflammatory and autoimmune disorders |
| 02/24/2005 | US20050042318 Controlling hormone sensitive diseases; solvent extraction of hops, filtration, desolventizing |
| 02/24/2005 | US20050042317 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 02/24/2005 | US20050042273 Covalently linking PDGF Nucleic Acid Ligand with a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound to form a Complex; diagnostic and therapeutic agent; improving pharmacokinetic properties |
| 02/24/2005 | US20050042202 Gentamicin, amikacin, tobramycin, netilmicin, cephalosporin, ceftazidine, maxalactam, carbopenem, imipenem, aztreonam, ampicillin, penicillin, ureidopenicillin, augmentin, amphotericin, famvir and/or acyclovir; and Vpr protein, fragment or nucleic acid encoding; systemic inflammatory response syndrome |
| 02/24/2005 | CA2743534A1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 02/24/2005 | CA2535619A1 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors |
| 02/24/2005 | CA2535416A1 Imidazopyridine derivatives |
| 02/23/2005 | EP1508619A1 Novel promoter |
| 02/23/2005 | EP1507875A2 Assay for identifying inhibitors of fc gamma riii signaling |
| 02/23/2005 | EP1507855A2 Elongase genes and uses thereof |
| 02/23/2005 | EP1507780A1 Pyrazolo-pyrimidine aniline compounds useful as kinase inhibitors |
| 02/23/2005 | EP1507767A1 4-substituted imidazole-2-thiones and imidazol-2-ones as agonists of the alpha-2b and alpha-2c adrenergic receptors |
| 02/23/2005 | EP1507765A2 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 02/23/2005 | EP1507760A1 Cyanoguanidine prodrugs |
| 02/23/2005 | EP1507758A2 Indole derivatives and their use as ligands for cb2 receptors |
| 02/23/2005 | EP1507756A1 Ccr9 inhibitors and methods of use thereof |
| 02/23/2005 | EP1507558A1 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
| 02/23/2005 | EP1507539A1 Hormone replacement therapy using a combination of conjugated estrogens and trimegestone |
| 02/23/2005 | EP1507537A1 Combination of an ace inhibitor, a calcium channel blocker and a diuretic |
| 02/23/2005 | EP1507535A1 Pyrimidine-2,4,6-trione metallo-proteinase inhibitors |
| 02/23/2005 | EP1507529A1 Combination of organic compounds |
| 02/23/2005 | EP1507528A2 Methods for using jnk inhibitors for treating or preventing disease-related wasting |
| 02/23/2005 | EP1507514A2 Controlled release compositions of estradiol metabolites |
| 02/23/2005 | EP1286986B1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain |
| 02/23/2005 | EP1107962B1 Quinolin-2-one derivatives useful as anticancer agents |
| 02/23/2005 | EP1066304B1 Macrolide lhrh antagonists |
| 02/23/2005 | EP1041980B1 Acyl guanidine sodium/proton exchange inhibitors and method |
| 02/23/2005 | EP0854709B2 Use of boswellic acid and its derivatives for inhibiting normal and increased leucocytic elastase or plasmin activity |
| 02/23/2005 | CN1585772A Chemokine receptor antagonists and methods of use thereof |
| 02/23/2005 | CN1585771A Polycyclic guanine derivative phosphodiesterase V inhibitors |
| 02/23/2005 | CN1585770A Reverse-turn mimetics and method relating thereto |
| 02/23/2005 | CN1585757A Oligopeptides and compositions containing them as cathepsin S inhibitors |
| 02/23/2005 | CN1585755A Benzamide and heteroarylamide as P2X7 receptor antagonists |
| 02/23/2005 | CN1585754A Quinazoline derivatives as antitumor agents |
| 02/23/2005 | CN1585752A 4, 4-difluoro-1, 2, 3, 4-tetrahydro-5H-1-benzazepine derivatives or salts thereof |
| 02/23/2005 | CN1585749A Cannabinoid receptor ligands |
| 02/23/2005 | CN1585748A NK1 antagonists |
| 02/23/2005 | CN1585745A Hydroxyfattysulfonic acid analogs |
| 02/23/2005 | CN1585640A N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation |
| 02/23/2005 | CN1585638A Linked biaryl compounds |
| 02/23/2005 | CN1583156A Chinese herbal medicines for various stones and their preparation |
| 02/23/2005 | CN1583150A Medicinal spirit for nourishing liver and kidney |
| 02/23/2005 | CN1583130A Frozen dry powder injection of houttuynia cordata and its preparation |
| 02/23/2005 | CN1583112A Capsules for nourishing kidney and strengthening yang |
| 02/23/2005 | CN1583042A Yanreqing capsules and their preparation |
| 02/23/2005 | CN1583029A Medicine for prostate hyperplasia and its preparation |
| 02/23/2005 | CN1582984A Frozen dry powder injection of astrogalus root and its preparing method |
| 02/23/2005 | CN1582936A External used gel of Jiatishacin and its preparation |
| 02/23/2005 | CN1582905A Use of emodin in preparation of antagonistic TGF beta-1 and medicines to prevent tissues from fibrosis |
| 02/23/2005 | CN1190491C PRV-gene and use thereof |
| 02/23/2005 | CN1190231C Chinese medicine for curing acute nephritis |
| 02/23/2005 | CN1190206C Chinese medicine 'Shenkangwan' bolus and its production process |
| 02/23/2005 | CN1190191C Use of Radix scutelariae glycoside in preparing medicine for treating prostatic disorders and its medicinal composition |
| 02/23/2005 | CN1190186C Carbohydrate medical solution and sulphite stabilisator in multiple compartment container and use thereof |
| 02/22/2005 | US6858650 Stable salts of novel derivatives of 3,3-diphenylpropylamines |
| 02/22/2005 | US6858629 Heteroaryloxy propanolamines, preparation method and pharmaceutical compositions containing same |
| 02/22/2005 | US6858621 Mbreast and prostate anticancer agents; viricides; alopecia |
| 02/22/2005 | US6858620 For therapy of male erectile dysfunction; female arousal disorder |
| 02/22/2005 | US6858602 Compounds for the treatment of metabolic disorders |
| 02/22/2005 | US6858594 Compounds and methods for treating urinary incontinence |
| 02/22/2005 | US6858581 Peptides which are modified with at least one hydrocarbyl group and which possess antimicrobial acitivity |
| 02/22/2005 | US6858228 Compression of drug and adjuvant |
| 02/22/2005 | CA2236256C A pharmaceutical composition for the treatment of autoimmune diseases |
| 02/17/2005 | WO2005014580A1 Pyridyl piperazinyl ureas |
| 02/17/2005 | WO2005014576A1 Isoquinolinone derivative, process for producing the same and use thereof |
| 02/17/2005 | WO2005014572A1 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 02/17/2005 | WO2005013986A1 Pyridylpyrrole derivatives active as kinase inhibitors |